Mariner
MPT

Mariner’s Medical Properties Trust MPT Stock Holding History

Mariner’s Portfolio MPT Stock Details MPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.42M Buy
523,925
+49,678
+10% +$246K ﹤0.01% 1373
2026
Q1 		$2.2M Sell
474,247
-106,446
-18% -$555K ﹤0.01% 1480
2025
Q4 		$2.91M Buy
580,693
+190,485
+49% +$992K ﹤0.01% 1291
2025
Q3 		$1.98M Buy
390,208
+203,499
+109% +$896K ﹤0.01% 1443
2025
Q2 		$805K Buy
186,709
+19,792
+12% +$97.8K ﹤0.01% 1968
2025
Q1 		$1.01M Buy
166,917
+78,553
+89% +$397K ﹤0.01% 1685
2024
Q4 		$349K Sell
88,364
-45,848
-34% -$205K ﹤0.01% 2494
2024
Q3 		$787K Sell
134,212
-63,866
-32% -$315K ﹤0.01% 1790
2024
Q2 		$858K Sell
198,078
-17,555
-8% -$84.1K ﹤0.01% 1625
2024
Q1 		$1.01M Buy
215,633
+46,175
+27% +$177K ﹤0.01% 1488
2023
Q4 		$832K Buy
169,458
+27,671
+20% +$135K ﹤0.01% 1565
2023
Q3 		$773K Sell
141,787
-138,078
-49% -$1.11M ﹤0.01% 1482
2023
Q2 		$2.59M Buy
279,865
+68,761
+33% +$582K 0.01% 875
2023
Q1 		$1.73M Sell
211,104
-9,878
-4% -$109K 0.01% 1019
2022
Q4 		$2.46M Buy
220,982
+161,754
+273% +$1.88M 0.01% 837
2022
Q3 		$702K Buy
59,228
+4,122
+7% +$62.4K ﹤0.01% 1227
2022
Q2 		$842K Buy
55,106
+5,351
+11% +$96.3K ﹤0.01% 965
2022
Q1 		$1.05M Buy
49,755
+26,477
+114% +$571K ﹤0.01% 921
2021
Q4 		$550K Buy
23,278
+1,194
+5% +$25.6K ﹤0.01% 982
2021
Q3 		$443K Sell
22,084
-3,047
-12% -$62.4K ﹤0.01% 872
2021
Q2 		$505K Buy
25,131
+410
+2% +$8.77K ﹤0.01% 787
2021
Q1 		$526K Buy
24,721
+9,417
+62% +$203K ﹤0.01% 732
2020
Q4 		$333K Sell
15,304
-260
-2% -$5.07K ﹤0.01% 739
2020
Q3 		$274K Sell
15,564
-2,348
-13% -$43.7K ﹤0.01% 683
2020
Q2 		$337K Buy
17,912
+410
+2% +$7.26K ﹤0.01% 662
2020
Q1 		$305K Sell
17,502
-8,583
-33% -$179K ﹤0.01% 649
2019
Q4 		$551K Buy
26,085
+10,197
+64% +$206K 0.01% 599
2019
Q3 		$311K Sell
15,888
-27,126
-63% -$498K ﹤0.01% 643
2019
Q2 		$750K Buy
43,014
+6,996
+19% +$126K 0.01% 597
2019
Q1 		$667K Buy
+36,018
New +$642K 0.01% 585

Other funds holding MPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Mariner's MPT Position: Q2 2026 in Review

Mariner increased its Medical Properties Trust (MPT) stake by 10% in Q2 2026, buying an estimated $246K and bringing the position to 523,925 shares worth $2.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1373.

Mariner first reported a position in MPT in Q1 2019 and has held it in 30 quarters since. The position peaked at $2.91M in Q4 2025. 489 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

  • Mariner held 523,925 shares of Medical Properties Trust worth $2.42M as of Q2 2026.
  • Mariner bought 49,678 Medical Properties Trust shares in Q2 2026, an estimated $246K.
  • Medical Properties Trust made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1373 holding.
  • Mariner first reported a position in Medical Properties Trust in Q1 2019 and has held it in 30 quarters since.
  • Mariner's Medical Properties Trust position peaked at $2.91M in Q4 2025.
  • 489 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.